Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 85 - 96 items out of 262 results
ILCN article
Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade
ILCN article
Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits
ILCN article
Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis, and Prognostication
ILCN article
Grappling with Coronavirus (SARS-CoV-2)
ILCN article
Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC
ILCN article
Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia
ILCN article
TRK Inhibition in TRK Fusion–Positive Lung Cancers
ILCN article
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr. Edgardo S. Santos Castillero
ILCN article
CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in NSCLC
ILCN article
Smoking Ban in Austria Passed After Years of Political Wrangling
ILCN article
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC
ILCN article
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
Pagination
First
First page
‹
Previous page
…
4
5
6
7
8
9
10
11
12
…
›
Next page
Last
Last page